Kylie H. Kang

Reexpression of Tumor Suppressor, sFRP1, Leads to Antitumor Synergy of Combined HDAC and Methyltransferase Inhibitors in Chemoresistant Cancers

Simon Cooper, Christina A. Von Roemeling, Kylie H. Kang et al. · Molecular Cancer Therapeutics · 2012 · 56 citations · Full text

Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients

Katelyn M. Atkins, Itai Pashtan, Marc R. Bussière et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 42 citations

Adaptive Radiotherapy, Neuro-oncology, Medical Imaging +12

Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Tithi Biswas, Kylie H. Kang, Rohin Gawdi et al. · International Journal of Environmental Research and Public Health · 2020 · 23 citations · Full text

Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer

Kylie H. Kang, Jimmy T. Efird, Neelesh Sharma et al. · Future Oncology · 2017 · 19 citations

Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer

R Chin, Ebunoluwa Otegbeye, Kylie H. Kang et al. · JAMA Network Open · 2022 · 14 citations · Full text